Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.

BMC infectious diseases - 14 Sept 2018

Adland Emily, Jesuthasan Gerald, Downs Louise, Wharton Victoria, Wilde Gemma, McNaughton Anna L, Collier Jane, Barnes Eleanor, Klenerman Paul, Andersson Monique, Jeffery Katie, Matthews Philippa C

Abstract excerpt

BACKGROUND: As direct acting antiviral (DAA) therapy is progressively rolled out for patients with hepatitis C virus (HCV) infection, careful scrutiny of HCV epidemiology, diagnostic testing, and access to care is crucial to underpin improvements in delivery of treatment, with the ultimate goal of elimination. METHODS: We retrospectively studied microbiology records from a large UK teaching hospital in order to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Hepatitis C Antibodies

Share to Hospitals, Teaching

Share to RNA, Viral

Share to Sustained Virologic Response

Share to United Kingdom

Source

Open in PubMed Open full text

Identifiers

PMID: 30217169
DOI: 10.1186/s12879-018-3367-3
PMCID: PMC6137907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort.PMID 30217169Read ↗

Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohortSemantic proximity Read ↗

Real-world outcomes of unrestricted direct-acting antiviral treatment for hepatitis C in Australia: The South Australian statewide experience.Semantic proximity Read ↗

Direct-acting antiviral therapy for hepatitis C: The initial experience of the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa.Semantic proximity Read ↗

Using surveillance data to determine treatment rates and outcomes for patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

A decade of hepatitis C at the University of Cape Town/Groote Schuur Hospital Liver Clinic, South Africa, in the pre-direct-acting antivirals era.Semantic proximity Read ↗

Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype.Semantic proximity Read ↗

Clinical features and therapeutic response in patients with HIV and acute HCV coinfection: a cohort studySemantic proximity Read ↗

Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.Semantic proximity Read ↗

Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom-Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa.Semantic proximity Read ↗

Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C.Semantic proximity Read ↗

Direct-acting antiviral therapy in HCV patients: a retrospective study of the pre- and post-treatment impact in Saudi Arabia.Semantic proximity Read ↗

Assessing hepatitis C virus distribution among vulnerable populations in London using whole genome sequencing: results from the TB-REACH studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.